Broncus Holding Future Growth
Future criteria checks 2/6
Broncus Holding is forecast to grow revenue at 25.6% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 39.9% |
Revenue growth rate | 25.6% |
Future return on equity | 0.3% |
Analyst coverage | Low |
Last updated | 31 Aug 2024 |
Recent future growth updates
Recent updates
We Think Broncus Holding (HKG:2216) Needs To Drive Business Growth Carefully
Mar 21Broncus Holding (HKG:2216) Is In A Good Position To Deliver On Growth Plans
Nov 30Will Broncus Holding (HKG:2216) Spend Its Cash Wisely?
May 31Companies Like Broncus Holding (HKG:2216) Are In A Position To Invest In Growth
Feb 27An Intrinsic Calculation For Broncus Holding Corporation (HKG:2216) Suggests It's 47% Undervalued
Dec 06Analysts Just Slashed Their Broncus Holding Corporation (HKG:2216) EPS Numbers
Sep 04Here's Why We're Not Too Worried About Broncus Holding's (HKG:2216) Cash Burn Situation
Jun 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 22 | N/A | -1 | 3 | 1 |
12/31/2025 | 17 | N/A | N/A | 3 | 1 |
12/31/2024 | 13 | N/A | -6 | 1 | 1 |
6/30/2024 | 9 | -21 | -20 | -19 | N/A |
3/31/2024 | 9 | -25 | -23 | -23 | N/A |
12/31/2023 | 10 | -28 | -27 | -26 | N/A |
9/30/2023 | 11 | -27 | -29 | -28 | N/A |
6/30/2023 | 11 | -27 | -31 | -30 | N/A |
3/31/2023 | 10 | -27 | -31 | -30 | N/A |
12/31/2022 | 9 | -28 | -32 | -31 | N/A |
9/30/2022 | 10 | -119 | -33 | -32 | N/A |
6/30/2022 | 11 | -209 | -35 | -34 | N/A |
3/31/2022 | 11 | -222 | -34 | -33 | N/A |
12/31/2021 | 11 | -236 | -33 | -31 | N/A |
9/30/2021 | 8 | -156 | -29 | -27 | N/A |
6/30/2021 | 5 | -76 | -26 | -23 | N/A |
3/31/2021 | 4 | -62 | -21 | -19 | N/A |
12/31/2020 | 3 | -48 | -17 | -16 | N/A |
12/31/2019 | 8 | -32 | -16 | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2216's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if 2216's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 2216's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2216's revenue (25.6% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).
High Growth Revenue: 2216's revenue (25.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2216's Return on Equity is forecast to be low in 3 years time (0.3%).